位置:首页 > 蛋白库 > T19H_CATRO
T19H_CATRO
ID   T19H_CATRO              Reviewed;         507 AA.
AC   F5BHA2;
DT   13-NOV-2019, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 1.
DT   03-AUG-2022, entry version 32.
DE   RecName: Full=Tabersonine/lochnericine 19-hydroxylase {ECO:0000303|PubMed:31009114};
DE            EC=1.14.14.- {ECO:0000269|PubMed:21454651, ECO:0000269|PubMed:31009114};
DE   AltName: Full=Cytochrome P450 71BJ1 {ECO:0000303|PubMed:21454651, ECO:0000303|PubMed:31009114};
GN   Name=T19H {ECO:0000303|PubMed:31009114};
GN   Synonyms=CYP71BJ1 {ECO:0000303|PubMed:21454651,
GN   ECO:0000303|PubMed:31009114};
OS   Catharanthus roseus (Madagascar periwinkle) (Vinca rosea).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; lamiids; Gentianales; Apocynaceae; Rauvolfioideae; Vinceae;
OC   Catharanthinae; Catharanthus.
OX   NCBI_TaxID=4058;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=21454651; DOI=10.1074/jbc.m111.225383;
RA   Giddings L.-A., Liscombe D.K., Hamilton J.P., Childs K.L., Dellapenna D.,
RA   Buell C.R., O'Connor S.E.;
RT   "A stereoselective hydroxylation step of alkaloid biosynthesis by a unique
RT   cytochrome P450 in Catharanthus roseus.";
RL   J. Biol. Chem. 286:16751-16757(2011).
RN   [2]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=29438577; DOI=10.1111/tpj.13868;
RA   Carqueijeiro I., Duge de Bernonville T., Lanoue A., Dang T.-T.,
RA   Teijaro C.N., Paetz C., Billet K., Mosquera A., Oudin A., Besseau S.,
RA   Papon N., Glevarec G., Atehortua L., Clastre M., Giglioli-Guivarc'h N.,
RA   Schneider B., St-Pierre B., Andrade R.B., O'Connor S.E., Courdavault V.;
RT   "A BAHD acyltransferase catalyzing 19-O-acetylation of tabersonine
RT   derivatives in roots of Catharanthus roseus enables combinatorial synthesis
RT   of monoterpene indole alkaloids.";
RL   Plant J. 94:469-484(2018).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=31009114; DOI=10.1111/tpj.14346;
RA   Williams D., Qu Y., Simionescu R., De Luca V.;
RT   "The assembly of (+)-vincadifformine- and (-)-tabersonine-derived
RT   monoterpenoid indole alkaloids in Catharanthus roseus involves separate
RT   branch pathways.";
RL   Plant J. 99:626-636(2019).
CC   -!- FUNCTION: Component of the monoterpenoid indole alkaloids (MIAs, e.g.
CC       echitovenine, tabersonine, lochnericine, 19-hydroxytabersonine and
CC       horhammericine) biosynthetic pathway; MIAs are used in cancer treatment
CC       and other medical applications (PubMed:31009114). Cytochrome P450
CC       catalyzing the conversion of (-)-tabersonine to 19-hydroxytabersonine,
CC       of lochnericine to horhammericine and of (-)-vincadifformine to (-)-
CC       minovincinine (PubMed:31009114, PubMed:21454651).
CC       {ECO:0000269|PubMed:21454651, ECO:0000269|PubMed:31009114}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(-)-tabersonine + O2 + reduced [NADPH--hemoprotein reductase]
CC         = (-)-(R)-19-hydroxytabersonine + H(+) + H2O + oxidized [NADPH--
CC         hemoprotein reductase]; Xref=Rhea:RHEA:61044, Rhea:RHEA-COMP:11964,
CC         Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:57893,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:144372;
CC         Evidence={ECO:0000269|PubMed:21454651, ECO:0000269|PubMed:31009114};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61045;
CC         Evidence={ECO:0000269|PubMed:21454651, ECO:0000269|PubMed:31009114};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lochnericine + O2 + reduced [NADPH--hemoprotein reductase] =
CC         H(+) + H2O + horhammericine + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:61048, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:144374,
CC         ChEBI:CHEBI:144375; Evidence={ECO:0000269|PubMed:21454651,
CC         ECO:0000269|PubMed:31009114};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61049;
CC         Evidence={ECO:0000269|PubMed:21454651, ECO:0000269|PubMed:31009114};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(-)-vincadifformine + O2 + reduced [NADPH--hemoprotein
CC         reductase] = (-)-minovincinine + H(+) + H2O + oxidized [NADPH--
CC         hemoprotein reductase]; Xref=Rhea:RHEA:61052, Rhea:RHEA-COMP:11964,
CC         Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:142771, ChEBI:CHEBI:144373;
CC         Evidence={ECO:0000269|PubMed:31009114};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61053;
CC         Evidence={ECO:0000269|PubMed:31009114};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:Q96242};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 nM for tabersonine (at pH 7 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:21454651};
CC         Vmax=5 umol/min/ug enzyme with tabersonine as substrate (at pH 7 and
CC         30 degrees Celsius) {ECO:0000269|PubMed:21454651};
CC   -!- PATHWAY: Alkaloid biosynthesis. {ECO:0000269|PubMed:21454651,
CC       ECO:0000269|PubMed:31009114}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:29438577}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Confined to roots. {ECO:0000269|PubMed:29438577}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ901597; ADZ48681.1; -; mRNA.
DR   AlphaFoldDB; F5BHA2; -.
DR   SMR; F5BHA2; -.
DR   KEGG; ag:ADZ48681; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR   GO; GO:0035835; P:indole alkaloid biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 1.10.630.10; -; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alkaloid metabolism; Endoplasmic reticulum; Glycoprotein; Heme; Iron;
KW   Lyase; Membrane; Metal-binding; Monooxygenase; Oxidoreductase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..507
FT                   /note="Tabersonine/lochnericine 19-hydroxylase"
FT                   /id="PRO_0000448557"
FT   TRANSMEM        8..28
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         447
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250|UniProtKB:Q96242"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ   SEQUENCE   507 AA;  57811 MW;  B59E8E1E9F3DB84F CRC64;
     MLSSLKDFFV LLLPFFIGIA FIYKLWNFTS KKNLPPSPRR LPIIGNLHQL SKFPQRSLRT
     LSEKYGPVML LHFGSKPVLV ISSAEAAKEV MKINDVSFAD RPKWYAAGRV LYEFKDMTFS
     PYGEYWRQAR SICVLQLLSN KRVQSFKGIR EEEIRAMLEK INQASNNSSI INGDEIFSTL
     TNDIIGRSAF GRKFSEEESG SKLRKVLQDL PPLLGSFNVG DFIPWLSWVN YLNGFEKKLN
     QVSKDCDQYL EQVIDDTRKR DEENGANNNG GNHGNFVSVL LHLQKEDVKG FPSEKGFLKA
     IILDMIVGGT DTTHLLLHWV ITELLKNKHV MTKLQKEVRE IVGRKWEITD EDKEKMKYLH
     AVIKEALRLH PSLPLLVPRV AREDINLMGY RVAKGTEVII NAWAIARDPS YWDEAEEFKP
     ERFLSNNFDF KGLNFEYIPF GSGRRSCPGS SFAIPIVEHT VAHLMHKFNI ELPNGVSAED
     FDPTDAVGLV SHDQNPLSFV ATPVTIF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024